Literature DB >> 534100

Ocular abnormalities occurring with vitiligo.

D M Albert, J J Nordlund, A B Lerner.   

Abstract

One hundred twelve patients with vitiligo were examined for ocular abnormalities. Discrete areas of depigmentation with associated pigment hyperplasia clinically appearing to involve the choroid and retinal pigment epithelium were observed in 44 patients, and active uveitis was seen in nine patients. The changes observed suggest that the spectrum of diseases that includes Harada's disease and the Vogt-Koyanagi syndrome may be broader than previously appreciated. Patients with these syndromes may represent the most severe examples of vitiligo and uveal inflammation. The occurrence of symptoms of night blindness in 12 patients and a family history of retinitis pigmentosa in two of these may signify a possible malfunction of the retinal pigment epithelium. Further evidence for a pigment epithelium disorder is suggested by the high incidence of an unusually prominent choroidal pattern in these patients.

Entities:  

Mesh:

Year:  1979        PMID: 534100     DOI: 10.1016/s0161-6420(79)35413-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  13 in total

1.  Ocular pathology in melanomatous Sinclair miniature swine.

Authors:  L Feeney-Burns; R P Burns; C L Gao
Journal:  Am J Pathol       Date:  1988-04       Impact factor: 4.307

2.  Audiological and Electrophysiological Changes in Patients with Vitiligo.

Authors:  Richa Arya; Sanjay Kumar Munjal; Naresh Kumar Panda; Davinder Prasad
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-08-23

3.  Prevalence of choroidal nevus and retinal pigment epithelial alterations in vitiligo patients.

Authors:  Efrat Fleissig; Mor Pavlovksy; Anat Loewenstein; Dinah Zur; Hadas Newman; Shay Keren; Dafna Goldenberg; Efrat Bar-Ilan; Michaella Goldstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-03-16       Impact factor: 3.117

4.  Ocular abnormalities associated with cutaneous melanoma and vitiligolike leukoderma.

Authors:  M A Chang; G Fournier; H K Koh; A J Sober; H Nakagawa; T B Fitzpatrick; D M Albert
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

5.  Vitiligo and disorders of the retinal pigment epithelium.

Authors:  D M Albert; M D Wagoner; R C Pruett; J J Nordlund; A B Lerner
Journal:  Br J Ophthalmol       Date:  1983-03       Impact factor: 4.638

6.  Progressive cytologic changes during the development of delayed feather amelanosis and associated choroidal defects in the DAM chicken line. A vitiligo model.

Authors:  R E Boissy; J R Smyth; K V Fite
Journal:  Am J Pathol       Date:  1983-05       Impact factor: 4.307

7.  Morphology of melanocytes in hair bulbs and eyes of vitiligo mice.

Authors:  R E Boissy; G E Moellmann; A B Lerner
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

Review 8.  Vitiligo--part 1.

Authors:  Roberto Gomes Tarlé; Liliane Machado do Nascimento; Marcelo Távora Mira; Caio Cesar Silva de Castro
Journal:  An Bras Dermatol       Date:  2014 May-Jun       Impact factor: 1.896

9.  The relationship between stress and vitiligo: Evaluating perceived stress and electronic medical record data.

Authors:  Steven W Henning; Dinesh Jaishankar; Levi W Barse; Emilia R Dellacecca; Nicola Lancki; Kirsten Webb; Linda Janusek; Herbert L Mathews; Ronald N Price; I Caroline Le Poole
Journal:  PLoS One       Date:  2020-01-27       Impact factor: 3.240

10.  (E)-4-(3,4-Dimethoxyphenyl)but-3-en-1-ol Enhances Melanogenesis through Increasing Upstream Stimulating Factor-1-Mediated Tyrosinase Expression.

Authors:  Jisu Park; Heesung Chung; Seung Hyun Bang; Ah-Reum Han; Eun-Kyoung Seo; Sung Eun Chang; Duk-Hee Kang; Eok-Soo Oh
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.